跳轉至內容
Merck
  • ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.

ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.

The Journal of clinical endocrinology and metabolism (2014-04-09)
Guilherme Asmar Alencar, Antonio Marcondes Lerario, Mirian Yumie Nishi, Beatriz Marinho de Paula Mariani, Madson Queiroz Almeida, Johanne Tremblay, Pavel Hamet, Isabelle Bourdeau, Maria Claudia Nogueira Zerbini, Maria Adelaide Albergaria Pereira, Gilberto Carlos Gomes, Manoel de Souza Rocha, Jose Luis Chambo, André Lacroix, Berenice Bilharinho Mendonca, Maria Candida Barisson Villares Fragoso
摘要

Primary macronodular adrenal hyperplasia (PMAH) is a rare cause of Cushing's syndrome, usually characterized by functioning adrenal macronodules and increased cortisol production. Familial clustering of PMAH has been described, suggesting an inherited genetic cause for this condition. The aim of the present study was to identify the gene responsible for familial PMAH. Forty-seven individuals of a Brazilian family with PMAH were evaluated. A single-nucleotide polymorphism-based genome-wide linkage analysis followed by whole-exome sequencing were then performed in selected family members. Additionally, 29 other patients with PMAH and 125 randomly selected healthy individuals were studied to validate the genetic findings. Moreover, PMAH tissue was also analyzed through whole-exome sequencing, conventional sequencing, and microsatellite analysis. A heterozygous germline variant in the ARMC5 gene (p.Leu365Pro) was identified by whole-exome sequencing in a candidate genomic region (16p11.2). Subsequently, the same variant was confirmed by conventional sequencing in all 16 affected family members. The variant was predicted to be damaging by in silico methods and was not found in available online databases or in the 125 selected healthy individuals. Seven additional ARMC5 variants were subsequently identified in 5 of 21 patients with apparently sporadic PMAH and in 2 of 3 families with the disease. Further molecular analysis identified a somatic mutational event in 4 patients whose adrenal tissue was available. Inherited autosomal dominant mutations in the ARMC5 gene are a frequent cause of PMAH. Biallelic inactivation of ARMC5 is consistent with its role as a potential tumor suppressor gene.

材料
產品編號
品牌
產品描述

Sigma-Aldrich
二氯甲烷, suitable for HPLC, ≥99.8%, contains amylene as stabilizer
Sigma-Aldrich
二氯甲烷, contains 40-150 ppm amylene as stabilizer, ACS reagent, ≥99.5%
Sigma-Aldrich
二氯甲烷, HPLC Plus, for HPLC, GC, and residue analysis, ≥99.9%, contains 50-150 ppm amylene as stabilizer
Sigma-Aldrich
二氯甲烷, anhydrous, ≥99.8%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
氢化可的松, BioReagent, suitable for cell culture
Sigma-Aldrich
二氯甲烷, ACS reagent, ≥99.5%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
二氯甲烷, puriss. p.a., ACS reagent, reag. ISO, ≥99.9% (GC)
Sigma-Aldrich
氢化可的松, γ-irradiated, powder, BioXtra, suitable for cell culture
Sigma-Aldrich
氢化可的松, ≥98% (HPLC)
Sigma-Aldrich
二氯甲烷, puriss., meets analytical specification of Ph. Eur., NF, ≥99% (GC)
Sigma-Aldrich
二氯甲烷, ACS reagent, ≥99.5%, contains 40-150 ppm amylene as stabilizer
Supelco
二氯甲烷, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
氢化可的松, Pharmaceutical Secondary Standard; Certified Reference Material
USP
氢化可的松, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
二氯甲烷, biotech. grade, 99.9%, contains 40-150 ppm amylene as stabilizer
Supelco
二氯甲烷, analytical standard
Sigma-Aldrich
二氯甲烷, suitable for HPLC, ≥99.9%, contains 40-150 ppm amylene as stabilizer
Sigma-Aldrich
氢化可的松, meets USP testing specifications
峰鉴别用氢化可的松, European Pharmacopoeia (EP) Reference Standard
Supelco
二氯甲烷, Selectophore, ≥99.5%
氢化可的松, European Pharmacopoeia (EP) Reference Standard
氢化可的松, British Pharmacopoeia (BP) Assay Standard